Immuneering (IMRX) Accumulated Expenses (2020 - 2024)
Immuneering (IMRX) has 5 years of Accumulated Expenses data on record, last reported at $4.6 million in Q3 2024.
- For Q3 2024, Accumulated Expenses rose 39.22% year-over-year to $4.6 million; the TTM value through Sep 2024 reached $4.6 million, up 39.22%, while the annual FY2023 figure was $5.2 million, 14.95% up from the prior year.
- Accumulated Expenses reached $4.6 million in Q3 2024 per IMRX's latest filing, up from $3.8 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $5.2 million in Q4 2023 and bottomed at $85792.0 in Q1 2022.
- Average Accumulated Expenses over 5 years is $2.5 million, with a median of $2.4 million recorded in 2023.
- Peak YoY movement for Accumulated Expenses: crashed 69.7% in 2021, then soared 2711.93% in 2023.
- A 5-year view of Accumulated Expenses shows it stood at $698992.0 in 2020, then plummeted by 69.7% to $211772.0 in 2021, then skyrocketed by 2025.4% to $4.5 million in 2022, then grew by 14.95% to $5.2 million in 2023, then fell by 11.23% to $4.6 million in 2024.
- Per Business Quant database, its latest 3 readings for Accumulated Expenses were $4.6 million in Q3 2024, $3.8 million in Q2 2024, and $2.6 million in Q1 2024.